BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Pharmaceutics International, Inc. Announces cGMP Aseptic Facilities Expansion


1/26/2012 11:18:47 AM

Hunt Valley, Maryland - Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization specializing in the development of difficult to formulate compounds, today announced it has commenced construction of their new 24,000 sq. ft. cGMP aseptic fill/finish manufacturing facility. The expansion of Pii's Hunt Valley campus is focused on meeting current client projects with near-term commercial manufacturing needs and new client demand for larger batch sizes.

Targeted for completion in the fourth quarter 2012, the new facility will more than double the company's current sterile GMP manufacture capacity. Fill/finish suites will include automated vial and syringe filling, inspection and labeling equipment capable of producing batch sizes of 100,000 plus units.

The facility expansion closely follows the company's recent United States Food and Drug Administration (FDA) pre-approval inspection (PAI). As a result of this inspection Pii was approved to commercially manufacture an aseptic vial in their existing Hunt Valley aseptic facility.

"Pii has demonstrated its expertise in sterile product development and aseptic manufacturing, offering our clients a quality product with strict adherence to regulatory compliance standards," stated Steve King, senior vice president of Pii. "The additional facilities will enable us to support our clients from pre-clinical through commercial-scale production and meet the growing demand for fill/finish services for potent compounds and oncology drugs."

About Pii

Pharmaceutics International, Inc. (Pii) is a privately held contract development and manufacturing company providing dosage form development and GMP manufacturing services to the global pharmaceutical industry. Pii's vision is to become the benchmark in pharmaceutical product development and commercial manufacturing outsourcing. Headquartered in Hunt Valley, Maryland USA with European facilities in the UK, Pii offers preformulation testing, formulation development and Clinical Trial Material and commercial manufacture of solid, parenteral, inhalation, semi-solid and liquid dosage forms. For further information about PII visit www.pharm-int.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES